HIV mutation literature information.


  HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.
 PMID: 21390473       2010       Acta dermatovenerologica Alpina, Pannonica, et Adriatica
Abstract: Ninety percent of sequences with genotypic resistance harbored M184V, M41L, K103N, D67N, and/or T215Y.


  Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.
 PMID: 23875516       2010       Boletin de la Asociacion Medica de Puerto Rico
Abstract: The reverse transcriptase mutations with the highest frequency of expression were M184V, K103N and D67N.
Result: Analysis of RT mutations for 2005 demonstrated that the highest degree of expression was for M184V (41.3%), K103N (25.3%), and D67N (20.5%).


  Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.
 PMID: 19064892       2009       Antimicrobial agents and chemotherapy
Abstract: In HIV-1 subtype B, TFV-3TC and ZDV-3TC selected for M184I and D67N, respectively.


  Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
 PMID: 19133804       2009       Clinical infectious diseases
Table: D67N


  Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.
 PMID: 19143530       2009       Clinical infectious diseases
Abstract: HIV-1-associated thymidine analogue mutations (M41L, D67N, K70R, L210W, and T215Y/F) were not observed, with the exception of K70R, which was present together with K65R and Q151M in a strain from 1 patient.
Result: HIV-1-associated thymidine analogue mutations (M41L, D67N, K70R, L210W, T215Y/F, and K219Q/E) were not found, with the exception of K70R, which was present in a strain from 1 patient (in conjunction with K65R


  Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.
 PMID: 19277127       2009       PloS one
Table: D67N


  The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.
 PMID: 19417582       2009       AIDS (London, England)
Method: NRTI mutations included K65R and K70E (associated with TDF resistance), thymidine analog mutations (TAMs) M41L, D67N, K70R, L210W, T215Y, T215F, K219Q, and K219E, and multinucleoside mutations, including the 69 insertion complex and the 151 complex.
Result: The most frequent TAMs were T215 F/Y (73%), D67N (53%), K70R (36%), M41L (36%), K219 Q/E (23%), and L210W (23%).


  Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients.
 PMID: 19428602       2009       Antiviral research
Introduction: The excision mechanism is associated with mutations at the polymerase domain, including M41L, D67N, K70R, L210W, T215F/Y and K219E/Q (excision-containing mutations, EEMs, also known as thymidine analogue-associated mutations [TAMs]).
Result: Among these isolates, 6 contained the known RTI-associated resistant mutations, D67N (n=2), K238S (n=2) (http://www.hiv.lanl.gov/content/index), V108I/K238S (n=1) and V106A/V108I/K238S (n=1), and thus were


  Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance.
 PMID: 19433560       2009       Antimicrobial agents and chemotherapy
Abstract: Two (1.6%) unrelated patients harbored nucleoside reverse transcriptase inhibitor- and nonnucleoside reverse transcriptase inhibitor-resistant viruses (mutations: M41L, D67N, M184V, L210W, T215Y or T215F, and K103N).


  Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.
 PMID: 19474474       2009       Antiviral therapy
Abstract: HIVDR prevalence in Douala was low for PIs and NNRTIs, and moderate for NRTIs as we identified one individual with M184V plus K101E plus G190A mutations and a second with D67D/N.
Abstract: In Yaounde, we found one individual with the D67D/N mutation and two with K103N.



Browser Board

 Co-occurred Entities




   Filtrator